close
MENU
Hot Topic Long reads
Hot Topic Long reads
General Business
7 mins to read

Why isn’t NZ staking its claim in a $US240b global industry?

Ecolibrium Biologicals wanted to stay in NZ but headed for multinational deal.

The founder of a Pukekohe-based agri-biotech company says that with government investment New Zealand’s greentech industry could lead the world, creating jobs and wealth.

Stephen Ford is the founder and technical director of Ecolibrium Biologicals, which develops and commercialises

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$385+GST / monthly

$38.5 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$660+GST / monthly

$33 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1375+GST / monthly

$27.5 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$2100+GST / monthly

$21 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Contact the Writer: nicola@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Why isn’t NZ staking its claim in a $US240b global industry?
General Business,
84500
true